Company / Capital Returned to Shareholders
Bruker Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$32.8M
FY2025
5-year range
$30.2M / $292.9M
FY2021-FY2025
Trend
+8.6%
vs FY2024
Sector context
#76 of 103
Health Care
What the data says
At $33M, Bruker's capital returned to shareholders ranks #76 of 103 in the Health Care sector. Capital Returned to Shareholders returned to growth in FY2025 after 2 years of decline, reaching $33M.
Based on SEC 10-K filings.
$33M in FY2025 with a 5-year CAGR of -26.0%.
Declined from $182M to $33M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -51.8%
- 5-Year CAGR
- -26.0%
- 10-Year CAGR
- -
Sector benchmark
#76 of 103 in Health CareTop 74% of 103This company $32.8M Sector average $732.9M
▼
-95.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -26.0%, indicating a declining trend.
- In FY2025, capital returned to shareholders increased 8.6% year-over-year.
- Ranks #76 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2022.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.8M | +8.6% |
| FY2024 | $30.2M | -83.4% |
| FY2023 | $181.7M | -38.0% |
| FY2022 | $292.9M | +65.0% |
| FY2021 | $177.5M | +20.1% |
| FY2020 | $147.8M | -11.7% |
| FY2019 | $167.3M | +2555.6% |
| FY2018 | $6.3M | -96.0% |
| FY2017 | $158.6M | -14.6% |
| FY2016 | $185.8M | +106.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026